Resumo
In this study, a bioguided fractionation of Plectranthus mutabilis extract was performed by chromatographic methods. It yielded one new nor-abietane diterpene, mutabilol (1), and three known abietanes, coleon-U-quinone (2), 8α,9α-epoxycoleon-U-quinone (3), and coleon U (4). The abietane diterpenoid 5 was also tentatively identified using HPLC-MS/MS. Moreover, the extract profile and quantification of each isolated compound were determined by HPLC-DAD. Compound 4 was the major compound in the extract. Compounds 2-4 were found to be selective toward cancer cell lines and were able to inhibit P-glycoprotein (P-gp) activity in NCI-H460/R cells at longer exposure of 72 h and consequently revert doxorubicin (DOX) resistance in subsequent combined treatment. None of the compounds influenced the P-gp expression in NCI-H460/R cells, while the extract significantly increased it.
Idioma original | Inglês |
---|---|
Páginas (de-até) | 674-680 |
Número de páginas | 7 |
Revista | ACS Medicinal Chemistry Letters |
Volume | 13 |
Número de emissão | 4 |
DOIs | |
Estado da publicação | Publicadas - 14 abr. 2022 |
Nota bibliográfica
Publisher Copyright:© 2022 American Chemical Society. All rights reserved.
Financiamento
Financiadoras/-es | Número do financiador |
---|---|
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja | 200007, 451-03-9/2021-14/200007 |
Fundação para a Ciência e a Tecnologia | UIDP/04567/2020, UIDB/04567/2020 |
Nemzeti Kutatási Fejlesztési és Innovációs Hivatal | K134704 |